Fact-checked by Grok 2 weeks ago

Lymph node

A lymph node is a small, bean-shaped structure that is a key component of the , functioning primarily to filter fluid from tissues, trap pathogens and abnormal cells, and facilitate immune responses by housing lymphocytes and other immune cells. These nodes, typically 1 to 2 cm in size, are distributed throughout the body in clusters, with approximately 600 to 800 present in an adult human, concentrated in areas such as the , armpits, , chest, and . They receive via afferent vessels, process it through internal sinuses and compartments, and return filtered fluid to the bloodstream via efferent vessels, thereby maintaining and preventing the spread of infections or malignancies. Structurally, each lymph node is encapsulated by a fibrous layer and divided into distinct regions: the outer cortex containing B-cell follicles for antibody production, the paracortex rich in T-cells for , and the inner medulla with cords and sinuses for further filtration by macrophages. High endothelial venules within the node allow circulating lymphocytes to enter and interact with antigens, enabling the activation of adaptive immune responses. Blood supply to the node supports these cellular activities, with arteries and veins ensuring nutrient delivery and waste removal. Lymph nodes play a vital role in both innate and adaptive immunity by engulfing and destroying , viruses, and debris through , while also initiating the production of antibodies and memory cells upon detecting threats. In clinical contexts, enlarged or tender lymph nodes often signal infections, autoimmune conditions, or cancers like , serving as diagnostic indicators through or imaging. Their strategic placement along lymphatic drainage pathways allows them to act as sentinel checkpoints, protecting specific body regions from systemic spread of disease.

Anatomy

Location and distribution

Lymph nodes are secondary lymphoid organs distributed throughout the body, strategically positioned to intercept and filter from various tissues before it returns to the bloodstream. In adults, there are approximately 600 to 800 lymph nodes, with the exact number varying by individual due to factors such as and status. These nodes are organized into clusters primarily in the (neck), axillary (armpit), inguinal (), mediastinal (chest), abdominal, and pelvic regions, where they align along the pathways of lymphatic vessels and major blood vessels to facilitate efficient drainage. The distribution of lymph nodes can be broadly categorized into superficial and deep groups. Superficial nodes are located in subcutaneous tissues and are more accessible, such as those in the cervical chain along the external jugular vein or the inguinal nodes below the inguinal ligament; these drain skin and superficial structures. In contrast, deep nodes are embedded within deeper tissues, often accompanying major arteries and veins, including the deep cervical nodes along the internal jugular vein, mediastinal nodes in the thoracic cavity, and iliac nodes in the pelvis; these handle drainage from internal organs and muscles. This superficial-deep organization reflects the parallel structure of the lymphatic system, which mirrors the venous network while providing complementary drainage./19%3A_Lymphatic_System/19.2%3A_Lymphatic_Vessels/19.2B%3A_Distribution_of_Lymphatic_Vessels) Functionally, lymph nodes are grouped into drainage pathways specific to organs or regions, with nodes serving as the initial filters in these routes—for example, axillary nodes for tissue or inguinal ones for lower limb structures. This arrangement ensures that lymph from peripheral sites flows through sequential node clusters toward central ducts, integrating with the broader for systemic circulation.

Size and morphology

Lymph nodes in humans are typically small, ovoid or bean-shaped structures measuring 0.5 to 2 cm in their longest dimension during rest, with a normal long axis generally not exceeding 1 cm. They exhibit a reniform (kidney-like) morphology, featuring a convex outer surface and a concave hilum where blood vessels and lymphatics enter and exit. This shape facilitates efficient lymph filtration and is consistent across most regional nodes, though size can vary slightly by location; for instance, inguinal nodes may reach up to 2.5 cm due to higher drainage volumes. Morphological variations exist across mammalian species, with nodes being distinctly ovoid and encapsulated in . In such as mice and rats, lymph nodes are similarly ovoid but proportionally smaller relative to body size, often displaying more pronounced medullary sinuses and differences in afferent drainage patterns compared to humans. These comparative traits highlight evolutionary adaptations in lymphoid organization while maintaining core structural similarities for immune function. On gross examination, normal lymph nodes possess a soft yet elastic consistency, allowing without undue firmness, and a glistening cut surface that appears gray-tan in color. This texture reflects their composition of lymphoid supported by a fibrous capsule, contributing to during immune . Age-related changes lymph node dimensions and structure, with nodes in children typically smaller than in adults, often under 1 cm in diameter in non-reactive states. In the elderly, nodes may undergo , resulting in reduced size, increased , and fat replacement, which diminishes overall lymphoid volume. These alterations underscore the dynamic nature of nodal morphology across the lifespan.

Capsule and external features

The capsule of a lymph node is composed of dense fibrous containing collagenous fibers, forming a tough outer layer that encloses the entire structure. This capsule is continuous with internal trabeculae, which are extensions of the same that radiate inward to provide structural support and compartmentalization within the node. Externally, lymph nodes exhibit a characteristic hilum, an indented region typically located on the medial side, serving as the primary site for the entry and exit of vessels. Multiple afferent lymphatic vessels penetrate the capsule near the hilum to deliver unfiltered into the subcapsular , while one to two efferent lymphatic vessels exit from the hilum to carry filtered away. Additionally, an enters and a exits through the hilum, often terminating in high endothelial venules that facilitate trafficking. The capsule functions as a protective barrier, shielding the lymph node from mechanical encountered during flow and body , while also helping to contain potential pathogens and prevent their extracapsular dissemination. This structural integrity maintains the node's role in immune surveillance without compromising vascular or lymphatic access.

Internal subdivisions

Lymph nodes are internally compartmentalized into distinct zones that facilitate organized flow and immune processing. The outermost region is the , a peripheral layer rich in B cells and characterized by lymphoid follicles, which may be primary (dense aggregates of small lymphocytes) or secondary (featuring germinal centers during active responses). Beneath the lies the paracortex, a deeper zone primarily supporting T-cell functions through interactions with antigen-presenting cells. The innermost medulla consists of loosely arranged cords and sinuses oriented toward the hilum, where efferent vessels exit. Lymph enters the node via the subcortical , a spacious channel located just beneath the capsule and above the , which receives fluid from afferent lymphatics and distributes it inward through trabecular connections. This is lined by endothelial cells and supported by a of fibers, allowing lymph to percolate slowly while exposing it to resident cells. In the medulla, linear medullary cords extend parallel to the hilum, interspersed with medullary es that collect lymph from upstream cortical and trabecular pathways before channeling it into efferent lymphatics. These cords represent specialized compartments for production and cellular output, while the sinuses ensure efficient drainage. The structural integrity of these subdivisions is maintained by a framework of reticular fibers, composed of type III and produced by reticular cells, which form a delicate meshwork throughout the sinuses and to support cellular migration and lymph filtration. These zones are populated by various immune cells, with the favoring B cells, the paracortex T cells, and the medulla plasma cells, as detailed in the cellular composition section.

Cellular composition

Lymph nodes are primarily composed of lymphocytes, which form the bulk of their cellular and are organized in distinct zones. B lymphocytes (B cells) are concentrated in the cortical follicles, where they form primary follicles in resting states or secondary follicles with germinal centers during immune activation. These B cells constitute approximately 40% of the total lymphocytes in human lymph nodes. T lymphocytes (T cells) predominate in the paracortical region, comprising the remaining 60% of lymphocytes, and are further subdivided into CD4+ helper T cells and CD8+ cytotoxic T cells that interact closely within this T cell zone. Antigen-presenting cells, essential for initiating immune responses, include dendritic cells and macrophages. Dendritic cells are mainly located in the paracortex, where they capture and process antigens before presenting them to T cells via molecules. Macrophages reside primarily in the subcapsular, cortical, trabecular, and medullary sinuses, where they phagocytose pathogens, debris, and apoptotic cells from incoming . Supporting cells provide the structural framework for lymph node architecture and include reticular cells and fibroblasts. Reticular cells form a network of fibers throughout the node, particularly in the cortex and paracortex, creating conduits for lymph flow and supporting lymphocyte migration. Fibroblasts contribute to the stromal connective tissue, including the capsule and trabeculae, maintaining overall tissue integrity. High endothelial venules (HEVs) are specialized postcapillary venules lined with cuboidal endothelial cells, primarily found in the paracortex and medulla. These structures express adhesion molecules such as peripheral lymph node addressin (PNAd) and like CCL19 and CCL21, enabling the high-affinity entry of naïve lymphocytes from the bloodstream into the lymph node . The zonal distribution of these cell types aligns with the internal subdivisions of the lymph node, optimizing immune cell interactions.

Development and histology

Embryonic development

The embryonic development of lymph nodes originates from the lymphatic system's primordia, which arise during early human gestation. Around the 6th to 8th gestational week, endothelial buds sprout from the anterior and posterior cardinal veins, forming the initial lymph sacs or anlagen that serve as precursors to the lymphatic vasculature and nodes. These structures develop from mesenchymal tissue, with lymphangiogenic factors such as vascular endothelial growth factor C (VEGF-C) and its receptor VEGFR-3, along with Prox1 transcription factor expression in venous endothelium, guiding the specification and budding of lymphatic endothelial cells. By the 9th to 11th weeks, these lymph sacs begin to anastomose into a primitive network, and mesenchymal cells invade them to establish the stromal framework, capsule, and connective tissue that delineate the emerging lymph node primordia. Lymphoid colonization of these primordia occurs progressively as the nodes take shape. Hematopoietic stem cells and lymphoid progenitors, originating from intraembryonic sites like the aorta-gonad-mesonephros , begin seeding the developing nodes around the 11th to 12th weeks, with significant lymphocytic infiltration intensifying by the 12th to 14th week. Lymphoid tissue inducer (LTi) cells, derived from these hematopoietic lineages, interact with stromal organizer cells via lymphotoxin signaling to promote clustering and compartmentalization, leading to the formation of rudimentary T-cell and B-cell zones by mid-gestation (around 11-14 weeks). Small lymphocytes, including T cells, populate the paracortex, while initial B-cell aggregates appear in the outer cortex, marking the onset of immune surveillance capabilities within the nodes. Node maturation continues through late and into postnatal life. By 15-17 weeks, subcapsular sinuses and early vascular patterns emerge, with corticomedullary becoming evident by 25-38 weeks, establishing the basic architectural subdivisions. However, full development of secondary follicles and germinal centers, essential for maturation and responses, occurs postnatally in response to antigenic exposure and microbial colonization, driven by the influx of mature B and T cells and the of . This process remodels the nodal , expanding the conduit network and enhancing transport and presentation functions.

Histological organization

The histological organization of lymph nodes reveals a compartmentalized structure optimized for immune interactions, consisting of a , paracortex, and medulla, all supported by a reticular . Under hematoxylin and (H&E) , the general architecture appears with a thin fibrous capsule enclosing subcapsular and trabecular sinuses that channel flow, while the displays densely packed lymphocytes in follicles and the paracortex shows a more diffuse T-cell-rich zone. (IHC) further delineates cell populations, with markers such as and highlighting B cells in follicles, and identifying T cells in the paracortex, and marking B cells. In activated lymph nodes, secondary follicles within the cortex feature prominent germinal centers, which under H&E staining exhibit a pale-staining central area surrounded by a darker of small lymphocytes, often displaying a "" pattern due to scattered tingible body macrophages. These macrophages, characterized by abundant filled with phagocytosed apoptotic debris, are crucial for clearing cellular remnants during B-cell proliferation and selection. The germinal centers contain proliferating centroblasts in a dark zone and selected centrocytes in a light zone, with retaining antigens on their surfaces. The stromal framework, visualized via silver staining or IHC for reticular fibers, comprises a network of fibroblastic reticular cells (FRCs) producing type III collagen-rich fibers that form conduits for lymph and support migration throughout the . This reticular meshwork is denser in medullary cords and peripheral deep cortical units, providing structural integrity without impeding cellular trafficking. Notably, the cortical regions are largely avascular, relying on high endothelial venules (HEVs) for entry; these postcapillary venules, identifiable by their plump cuboidal under H&E, express adhesion molecules that facilitate selective immune cell homing, distinguishing lymph nodes from vascular-rich tissues like .

Vascular and lymphatic flow

Lymphatic flow into the lymph node begins with multiple afferent lymphatic vessels that enter the convex surface of the node, delivering from surrounding tissues directly into the subcapsular sinus located just beneath the capsule. From there, the percolates slowly through a network of sinuses that traverse the and paracortex, allowing for filtration by resident macrophages and exposure to lymphocytes within the lymphoid tissue. This pathway continues into the medullary sinuses, where further processing occurs before the filtered converges and exits via one or more efferent lymphatic vessels at the hilum, the indented region on the concave side of the node. The blood supply to the lymph node is provided by arteries that enter exclusively at the hilum, branching into smaller arterioles that distribute throughout the node. These arterioles give rise to capillaries primarily within the paracortex, where they form a dense to nourish the high concentration of . The capillaries drain into postcapillary venules, many of which specialize as high endothelial venules (HEVs) characterized by their cuboidal , which facilitates selective entry from the bloodstream. Venous drainage ultimately converges into a single exiting at the hilum, maintaining separation from the lymphatic compartments. Lymph flow dynamics within the node are characterized by a slow, unidirectional progression facilitated by one-way valves in the afferent and efferent vessels, which prevent and promote efficient trapping during the extended in the sinuses. This deliberate process, estimated to handle approximately 4 liters of per day post-nodal , ensures sieving and immune without rapid transit. While and pathways are anatomically distinct with no direct fluid exchange, limited integration occurs through macrophages that can phagocytose antigens from lymph and present them to blood-derived lymphocytes. Node locations along major lymphatic trunks influence regional flow patterns, directing lymph from specific drainage areas into chains of nodes for sequential filtration.

Function

Lymph filtration and circulation

Lymph nodes serve as primary filters for , processing fluid that drains from tissues through afferent lymphatic vessels into the subcapsular sinus. Here, subcapsular sinus macrophages (SSMs) mechanically trap particulate debris, antigens, and pathogens, such as viruses and , preventing their deeper penetration into the node. This trapping occurs via the macrophages' extended cellular processes that line the sinus floor, capturing particles like 200-nm beads and immune complexes without immediate degradation, thereby acting as a physical . In the medullary sinuses, medullary sinus macrophages (MSMs) further enhance through high phagocytic activity, internalizing and clearing larger volumes of lymph-borne and dying cells using large lysosomes. The filtration process contributes to fluid homeostasis by returning excess interstitial fluid to the bloodstream, maintaining overall balance. Lymph collected from tissues—primarily water, electrolytes, and proteins—is filtered through the node's sinuses and exits via efferent lymphatics, ultimately draining into the , which empties into the left . In a typical adult, this system processes and returns up to 2-4 liters of per day, accounting for the portion of filtrate not reabsorbed by capillaries. As an initial nonspecific barrier, lymph node filtration clears pathogens from incoming before they can disseminate systemically, providing a crucial first line of defense. SSMs and MSMs phagocytose , viruses, and other microbes, reducing their load in the and limiting spread without relying on adaptive immune specificity. This mechanical and phagocytic clearance in the sinuses establishes an early checkpoint, complementing downstream immune processes within the node.

Immune surveillance

Lymph nodes serve as critical checkpoints for immune surveillance, enabling the continuous monitoring of the body's tissues for pathogens and abnormal cells through the orchestrated trafficking of immune cells. Naive T and B lymphocytes constantly recirculate between the blood and lymphoid organs, entering lymph nodes primarily via high endothelial venules (HEVs) in a process mediated by adhesion molecules such as L-selectin and chemokine receptors including CCR7 binding to CCL21, as well as CXCR5 to CXCL13 for B cells. Once inside, these lymphocytes scan antigen-presenting cells within the paracortex and follicles before exiting through efferent lymphatic vessels, a step regulated by sphingosine-1-phosphate (S1P) gradients acting on the S1P1 receptor to promote egress. This recirculation ensures broad patrolling, with naive T cells predominantly traversing T cell zones and naive B cells favoring B cell areas, involving key cell types like lymphocytes and dendritic cells as detailed in the cellular composition section. Complementing lymphocyte recirculation, lymph nodes distinguish between resident and transient populations to enhance surveillance efficiency. cells, such as lymphatic endothelial cells lining the node's sinuses, provide and baseline , while transient dendritic cells migrate from peripheral tissues into the node via afferent lymphatics, guided by CCR7-CCL21 interactions. These migratory dendritic cells transport tissue-derived antigens to the node's interior, bridging peripheral challenges with central immune evaluation without initiating full responses. To prevent during this patrolling, lymph nodes incorporate tolerance mechanisms, particularly in the medulla where peripheral negative selection occurs. Lymphatic endothelial cells in the medullary sinuses express peripheral antigens and directly present self-antigens to delete autoreactive + T cells that escaped thymic selection, independent of the Aire. These cells also express to induce tolerance. This deletional tolerance maintains self-nonself discrimination amid constant cell influx. Under baseline conditions, immune surveillance in lymph nodes involves substantial cellular turnover, with approximately 10^10 to 2.5 × 10^10 recirculating daily in humans. Afferent carries a mix of , macrophages, and dendritic , while efferent is lymphocyte-dominant, reflecting the node's role in selective retention and release for ongoing vigilance.

Antigen presentation and response

Antigens entering the lymph node via afferent lymphatics are captured by migratory (DCs) that have taken up pathogens or in peripheral tissues. These DCs enter the subcapsular sinus and crawl along its floor before migrating into the paracortex, the T-cell zone, where they present to naïve T cells. Resident DCs in the lymph node sinuses also contribute to uptake directly from , facilitating rapid transport to the T-cell area via conduits or direct . In the paracortex, DCs process antigens for presentation on (MHC) and II molecules. MHC molecules load exogenous antigens derived from endosomal pathways, priming CD4+ T cells, while MHC molecules present endogenous or cross-presented antigens to CD8+ T cells, enabling cytotoxic responses. This T-cell priming involves stable interactions between DCs and naïve T cells, leading to T-cell proliferation, differentiation into effector subsets, and production such as IL-2 and IFN-γ. Activated T cells, particularly follicular helper T (Tfh) cells, then migrate to the T-B border to interact with B cells. B-cell activation occurs in the cortical follicles, where naïve B cells encounter antigens displayed on or directly from subcapsular macrophages. Tfh cells provide co-stimulatory signals via CD40L and cytokines like IL-21, promoting B-cell and . This initiates formation within follicles, where B cells undergo in the dark zone and affinity-based selection in the light zone, iterating between zones to refine affinity over several days. High-affinity B cells are selected through competition for and Tfh help, driving class-switch recombination and . Effector outputs from these responses include cytokine release by activated T cells to amplify and recruit additional immune cells, as well as the generation of T and B cells for long-term immunity. cells migrate to the medullary cords to secrete high-affinity antibodies, while cells persist in the or recirculate. This process builds on ongoing immune surveillance to mount targeted adaptive responses.

Pathology and clinical significance

Lymphadenopathy and swelling

Lymphadenopathy refers to the abnormal enlargement of lymph nodes, often resulting from an underlying or pathological process. It is classified into several types, including reactive lymphadenopathy due to infectious or inflammatory stimuli, malignant causes such as or , and autoimmune conditions like systemic lupus erythematosus or . Reactive lymphadenopathy is the most common form and typically benign, resolving once the inciting factor is addressed. Common causes of lymphadenopathy include bacterial and viral infections, which trigger lymph node swelling as part of the . For instance, viral infections like caused by Epstein-Barr virus often lead to , while bacterial infections such as or can cause localized enlargement. Vaccinations, such as those for or , can also induce transient reactive lymphadenopathy due to immune activation. Inflammatory conditions, including autoimmune diseases, further contribute by promoting chronic immune stimulation in the nodes. Clinically, lymphadenopathy presents with distinct features that aid in initial assessment. Tender, painful nodes are characteristic of acute inflammatory or infectious processes, reflecting active immune activity. In contrast, nontender nodes may indicate a more chronic or less inflammatory . The distribution further differentiates cases: localized lymphadenopathy involves contiguous lymph node groups draining a specific site, such as cervical nodes in head and neck infections, whereas generalized involvement affects two or more non-contiguous regions and suggests . Diagnostic evaluation of lymphadenopathy relies on key clinical clues to determine the need for further investigation. Nodes larger than 1 cm in diameter are generally considered enlarged in adults, though normal sizes can vary by location (e.g., up to 1.5 cm in inguinal nodes). Persistence beyond 2 weeks, particularly if accompanied by other symptoms like fever or , raises concern for underlying and prompts additional workup. For comparison, normal lymph nodes are typically smaller than 1 cm and non-palpable in healthy individuals.

Role in cancer

Lymph nodes serve as critical sites for the initial spread of cancer through lymphatic metastasis, where tumor cells from the primary site invade lymphatic vessels and migrate to regional tumor-draining lymph nodes (TDLNs). This process begins with cancer cells detaching from the primary tumor, entering the lymphatics via intravasation, and establishing micrometastases within the node, often before further dissemination to distant sites. Lymph node involvement is a key prognostic indicator, as it facilitates immune evasion and prepares cancer cells for hematogenous spread. In cancer staging, the N category of the TNM system assesses lymph node involvement to determine disease extent and guide . N0 indicates no regional lymph node , while N1, N2, and N3 denote increasing numbers or locations of affected nodes, such as 1-3 nodes for N1 in or involvement of contralateral/supraclavicular nodes for higher stages. This is essential for , as nodal correlates with reduced survival rates and influences decisions on therapies. Sentinel lymph biopsy (SLNB) is a targeted procedure to identify and examine the first lymph (s) draining the , providing prognostic information without extensive removal. A negative SLNB suggests low risk of further nodal spread, while positivity indicates potential micrometastases and may prompt additional intervention, improving disease-free survival outcomes. SLNB has become standard for early-stage cancers due to its accuracy in detecting metastases. Lymph node is particularly common in , where axillary nodes are frequently the first site of spread, affecting up to 40% of cases at . In , regional nodes along lymphatic drainage paths are primary targets, influencing survival based on burden. often involves mesenteric nodes, with nodal status determining needs.

Lymphedema and lymphatic disorders

is a characterized by the accumulation of protein-rich lymphatic fluid in the interstitial tissues, leading to swelling primarily in the or legs due to impaired lymphatic drainage. This disorder arises from dysfunction in the , including lymph nodes, resulting in an imbalance of Starling's forces that normally regulate fluid exchange between capillaries and tissues, causing excessive fluid retention. Causes of lymphedema are classified as primary or secondary. Primary lymphedema is congenital, stemming from genetic malformations of the lymphatic vessels and nodes present at birth, such as , which affects approximately 1 in 100,000 individuals in the United States. Secondary lymphedema results from acquired damage to the lymphatic system, including surgical removal of lymph nodes, as seen post-mastectomy for , parasitic infections like caused by Wuchereria bancrofti, or other injuries such as . The condition progresses through stages marked by increasing severity of and tissue changes. In early stage 1, swelling is pitting and reversible with elevation, reflecting initial fluid accumulation without significant . Stage 2 involves non-pitting due to developing , while stage 3 features severe, irreversible swelling with skin thickening and fat deposition, often termed . This progression is driven by chronic and disruption of Starling's equilibrium, where elevated interstitial from protein buildup exacerbates fluid leakage from capillaries. Beyond , other lymphatic disorders include and lymphatic malformations. is an acute inflammation of lymphatic vessels, typically caused by bacterial spreading from a , presenting with red streaks, fever, and tender lymph nodes. Lymphatic malformations are congenital anomalies involving malformed lymphatic channels that form fluid-filled cysts, often appearing at birth and potentially leading to localized swelling or complications like . Treatment for lymphedema and related disorders emphasizes non-surgical conservative measures to manage symptoms and prevent progression. Compression therapy, using bandages or custom-fitted garments, applies graduated pressure to promote lymphatic flow and reduce swelling. involves gentle, specialized massage techniques to stimulate fluid movement toward functional vessels, often combined with exercise to enhance muscle pump action. These approaches, part of complete decongestive therapy, focus on symptom control rather than cure.

Diagnostic procedures

Diagnostic procedures for lymph nodes are employed when enlargement or abnormalities are suspected, often prompted by clinical signs such as swelling. These methods range from non-invasive assessments to invasive sampling, allowing evaluation of node structure, cellular composition, and potential . serves as the initial clinical examination for superficial lymph nodes, involving gentle pressure to assess size, shape, consistency, mobility, and tenderness. Nodes larger than 1 in diameter, firm, fixed, or matted are considered abnormal and warrant further investigation. This technique is particularly useful for accessible regions like the , axillary, and inguinal areas but is limited for deep nodes. Imaging techniques provide detailed visualization without initial tissue sampling. is often the first-line modality for superficial nodes, evaluating size, shape, echogenicity, margins, and vascular pattern via Doppler; for instance, a short-to-long ratio less than 2 suggests malignancy with high accuracy. Computed tomography (CT) and are preferred for deep or internal nodes, assessing size, morphology, and involvement of surrounding structures, though they rely primarily on anatomical changes. Positron emission tomography (PET), typically combined with CT, measures metabolic activity using tracers like FDG, offering superior sensitivity and specificity for detecting active disease processes compared to structural imaging alone. Invasive procedures are pursued when imaging or palpation indicates concern, to obtain material for definitive analysis. Fine-needle aspiration (FNA) involves inserting a thin needle, often ultrasound-guided, to extract cells and fluid for cytological examination; it has a sensitivity of 85-97% and specificity of 98-100%, making it suitable for initial in accessible nodes. Core needle biopsy uses a larger, cutting needle to retrieve a core, providing histological detail and higher diagnostic yield than FNA, especially when guided by for precision. Excisional biopsy surgically removes the entire node under anesthesia, serving as the gold standard for comprehensive evaluation, particularly when architecture preservation is needed for accurate diagnosis. Following invasive sampling, examines the retrieved material under to identify cellular abnormalities, infections, or malignancies. This includes hematoxylin-eosin for general morphology, supplemented by or for specific markers, enabling differentiation of reactive, infectious, or neoplastic processes with near-complete accuracy when adequate tissue is available.

Comparison to spleen

Lymph nodes and the are both secondary lymphoid organs that play critical roles in immunity, but they differ markedly in structure to accommodate their distinct filtration environments. Lymph nodes feature a fibrous capsule enclosing a subcapsular that receives from afferent vessels, an outer divided into B-cell follicles and a T-cell paracortex, and an inner medulla with cords of lymphoid cells and macrophages alongside medullary sinuses for drainage. In contrast, the consists of red pulp, which comprises the majority of its volume and includes venous sinusoids for , and white pulp, organized into periarteriolar lymphoid sheaths (T-cell zones) and B-cell follicles surrounding central arteries, with a marginal zone bridging the two pulps for capture. Unlike lymph nodes, the lacks afferent lymphatic vessels and a subcapsular , as all incoming material arrives via rather than , and it is enveloped by a thin capsule without trabeculae extending deeply into the red pulp. Both organs contain similar lymphoid cell populations, including T and B lymphocytes, but the 's supports closer interaction with circulating elements. Functionally, lymph nodes primarily filter lymph fluid draining from tissues, trapping pathogens and antigens for presentation to immune cells, thereby facilitating adaptive responses to tissue-derived threats. The spleen, however, filters blood directly, with its red pulp macrophages removing aged or damaged red blood cells, recycling iron, and clearing blood-borne particles like or parasites, in addition to mounting immune responses via the white pulp to systemic antigens. While both organs support immune surveillance through antigen-presenting cells and lymphocyte activation, the spleen emphasizes hematologic maintenance—such as preventing accumulation of defective erythrocytes—roles absent in lymph nodes. In terms of location, lymph nodes are distributed throughout the body in clusters along lymphatic vessels, numbering approximately 800 in adults and concentrated in regions like the , axillae, , and to monitor specific drainage areas. The , by comparison, is a singular, encapsulated situated in the upper left quadrant of the , posterior to the and superior to the left , making it the largest dedicated lymphatic structure at about 12 cm long. Clinically, removal of the spleen () carries risks such as (OPSI), a fulminant from encapsulated bacteria like , with a lifetime incidence of 1-3% and mortality rate of 38-70%. Lymph node excision, often performed in or treatment, primarily risks due to disrupted lymphatic drainage, with odds increasing fivefold for 6-15 nodes removed and tenfold for 16 or more, particularly in axillary or inguinal dissections.

Comparison to tonsils and Peyer's patches

Lymph nodes, tonsils, and Peyer's patches are all secondary lymphoid organs that facilitate the initiation of adaptive immune responses by enabling encounter with lymphocytes, but they differ significantly in their structural organization and integration with the . Unlike lymph nodes, which are encapsulated structures with both afferent and efferent lymphatic vessels allowing lymph to flow through for filtration and transport, tonsils and Peyer's patches lack efferent lymphatics and are directly embedded within mucosal epithelia. This embedding in tonsils (oropharyngeal mucosa) and Peyer's patches (intestinal mucosa) positions them as specialized components of (MALT), where they rely on local drainage rather than a complete vascular lymphatic circuit. Functionally, while all three structures support antigen presentation and lymphocyte activation, tonsils and Peyer's patches are adapted for direct sampling of luminal antigens from mucosal surfaces, primarily through microfold (M) cells in the overlying follicle-associated epithelium, which transport antigens to underlying dendritic cells and lymphocytes for mucosal immunity, including IgA production. In contrast, lymph nodes primarily process antigens delivered via afferent lymph from peripheral tissues, serving as centralized hubs for systemic immune surveillance and responses that can disseminate effectors body-wide. Both tonsils and Peyer's patches promote tolerance to commensal microbes alongside immunity, with T-cell-dependent IgA class switching in Peyer's patches being a key feature, whereas lymph nodes emphasize broader T- and B-cell priming for circulating immunity. Locationally, lymph nodes are distributed systemically along lymphatic vessels at junctions with blood vasculature, enabling them to intercept antigens from diverse tissues, whereas tonsils are fixed in the oropharynx as part of Waldeyer's ring, and Peyer's patches form discrete aggregates in the small intestine's , optimizing exposure to inhaled or ingested antigens. Evolutionarily, MALT structures like tonsils and Peyer's patches represent ancient mucosal adaptations, with organized emerging in sarcopterygian fish as primitive lymphoid aggregates, while lymph nodes evolved as more centralized, encapsulated organs in higher vertebrates to coordinate systemic responses, integrating MALT-derived signals.

References

  1. [1]
    Anatomy, Lymph Nodes - StatPearls - NCBI Bookshelf - NIH
    Jul 25, 2023 · The primary function of lymph nodes is filtering interstitial fluid collected from soft tissues and eventually returning it to the vascular ...Introduction · Structure and Function · Embryology · Blood Supply and Lymphatics
  2. [2]
    Lymph system: MedlinePlus Medical Encyclopedia
    ### Summary of Lymph Nodes in the Lymphatic System
  3. [3]
    Anatomy, Lymphatic System - StatPearls - NCBI Bookshelf - NIH
    Mar 6, 2023 · Lymph nodes serve as a filter and function to monitor lymphatic fluid/blood composition, drain excess tissue fluid and leaked plasma ...
  4. [4]
    Swollen lymph nodes - Symptoms & causes - Mayo Clinic
    Apr 25, 2025 · Swollen lymph nodes most often happen because of infection from bacteria or viruses. Rarely, cancer causes swollen lymph nodes.
  5. [5]
    Lymph Node Locations & Function - Cleveland Clinic
    Mar 19, 2025 · Anatomy. Lymph nodes are located throughout your body, with clusters in your head and neck, armpits, chest, abdomen and groin.
  6. [6]
    Lymph Nodes - SEER Training Modules - National Cancer Institute
    They are widely distributed throughout the body along the lymphatic pathways where they filter the lymph before it is returned to the blood. Lymph nodes are not ...
  7. [7]
    Lymphatic System Anatomy - Vessels - Nodes - TeachMeAnatomy
    On average, an adult has around 400 to 450 different lymph nodes spread throughout the body – with the majority located within the abdomen.
  8. [8]
    Sentinel node biopsy - Mayo Clinic
    Oct 31, 2024 · Lymph node clusters. Lymph nodes are bean-sized groups of white blood cells. Hundreds of these nodes cluster all through the lymphatic system.Missing: function | Show results with:function
  9. [9]
    Lymph nodes | Radiology Reference Article - Radiopaedia.org
    Jan 10, 2020 · A normal lymph node is a small ellipsoid structure, approximately 0.1 to 2.5 cm in maximal length 2,3 . Nodes often possess a reniform morphology.
  10. [10]
    The lymphoid system: a review of species differences - PMC
    Residual hematopoietic activity can be found in rodent but not human, dog or NHP lymph nodes.
  11. [11]
    Comparative histology of lymph nodes from aged animals and ...
    Histological heterogeneity and medullary sinus dominance were much more evident in the human nodes than in those from animals, except for the guinea pig ...
  12. [12]
    The Lymph Node Revisited: Development, Morphology, Functioning ...
    Jan 25, 2010 · Though our work focused on the rat, nodal morphology is basically similar among eight examined mammal species including the human and the mouse ...Missing: rodent | Show results with:rodent
  13. [13]
    Lymphadenopathy - Clinical Methods - NCBI Bookshelf - NIH
    Particular attention should be directed to the size, shape, and consistency of enlarged nodes. Lymph nodes that are smooth and relatively soft, but slightly ...
  14. [14]
    Anatomy & histology-lymph nodes - Pathology Outlines
    Lymph node structures. Lymph node architecture. Gross description. Ovoid with gray-tan cut surface. Microscopic (histologic) description. At low power, lymph ...Missing: color texture consistency
  15. [15]
    Lymph node grossing - Libre Pathology
    Apr 6, 2025 · Gross interpretation. Normal lymph node: Firm (relative to adipose tissue). Glistening surface when cut. Pathologic lymph node: White lesions ...Missing: appearance texture
  16. [16]
    Evaluation of children with lympadenopathy - PMC - NIH
    In young children, 2 cm in the neck, 1 cm in the axilla and 1.5 cm in the inguinal region are considered normal values and they do not require investigation. In ...
  17. [17]
    Aging-Related Cellular, Structural and Functional Changes in the ...
    Aging causes progressive disruption of the lymph nodes as their number and size are reduced, and structure becomes disorganized. The most affected are the ...
  18. [18]
    Degenerative Changes in Aging Human Pelvic Lymph Nodes—A ...
    In this study, it was shown that the pelvic lymph nodes show more degenerative changes with age, such as increased lipomatous atrophy, calcifications, framework ...
  19. [19]
    Age-dependent histoarchitectural changes in human lymph nodes
    Experimental evidence indicates that lymph nodes in humans undergo alterations during ageing. This is clinically important because of the crucial role of these ...
  20. [20]
    Lymphoid tissue: Lymph nodes - The Histology Guide
    The nodes are covered by a capsule of dense connective tissue, and have capsular extensions, of connective tissue, called the trabeculae, which provide ...
  21. [21]
    Histology, Lymph Nodes - StatPearls - NCBI Bookshelf - NIH
    Microscopy, Light. The lymph node capsule is thin fibrous, which receives afferent lymphatics. The naïve lymph node has not received any antigenic ...Missing: composition | Show results with:composition
  22. [22]
    Lymph nodes: Definition, anatomy and locations | Kenhub
    Lymph nodes are secondary lymphoid organs widely distributed throughout the body. They are strategically located at areas that are open to foreign ...
  23. [23]
    Distribution of T and B lymphocytes in lymphoid tissue of infants and ...
    Fifty percent of lymph node cells were either T or B cells; 65% of these cells were T lymphocytes, whereas 58% of B cells were of the IgM subclass. Less ...
  24. [24]
    The lymph node at a glance – how spatial organization optimizes ...
    Within the cortex are niches containing primarily B cells and follicular dendritic cells (FDCs), known as B cell follicles, as well as the interfollicular zone ...
  25. [25]
    Lymphatic drainage pathways from the cervix uteri
    The human lymphatic system starts to develop out of lymph sacs that arise from developing veins by the end of the 5th embryonic week. The main lymphatics are ...
  26. [26]
    Physiology, Lymphatic System - StatPearls - NCBI Bookshelf
    The embryologic development of the lymphatic system begins with the embryonic ... immune cells are delivered to lymph nodes providing adaptive immune protection.Missing: timeline | Show results with:timeline
  27. [27]
    None
    ### Summary of Embryonic and Fetal Development of Human Lymph Nodes
  28. [28]
    Lymph Nodes and Lymphatics
    From the 12th week of gestation until term, T-cells circulate in the periphery and settle into the growing lymph nodes [5,9]. This influx of lymphocytes from ...
  29. [29]
    Establishment of tissue-resident immune populations in the fetus
    In humans, GALT, including lamina propria, mesenteric lymph nodes (mLN), and Peyer's patches (PP), begins to develop 11–12 PCW, and at gestational week 19 the ...
  30. [30]
    The Development of the Human Immune System (Chapter 3)
    Lymph nodes first appear around 11 weeks post-conception, and lymphocytes appear within the lymph nodes approximately 1 week later. ... The human embryo ...
  31. [31]
    Normal Structure, Function, and Histology of Lymph Nodes
    This review paper was oriented toward helping the bench pathologist develop an appreciation of normal lymph node anatomy and function.
  32. [32]
    Lymphatic System - Duke Histology
    As the artery enters the node, it divides sending branches into the cortex to perfuse the follicles and others to travel within the capsule and trabeculae. The ...Missing: supply | Show results with:supply
  33. [33]
    Lymphatic System Flows - PMC - PubMed Central - NIH
    Jan 1, 2019 · The lymphatic vascular system scavenges this water and protein, ultimately returning it to the venous circulation via junctions with the ...<|control11|><|separator|>
  34. [34]
    Lymph Node Macrophages - PMC - NIH
    The highly phagocytic MSMs mediate clearance of particulates, pathogens and dying cells from the lymph, while MCMs may support plasma cell survival and clear ...
  35. [35]
    Anatomy, Thorax, Thoracic Duct - StatPearls - NCBI Bookshelf
    Lymph then moves through lymphatic vessels to lymph nodes. Lymphatic vessels ... During the sixth week of development of the human embryo, the early ...
  36. [36]
    Thoracic Duct - an overview | ScienceDirect Topics
    The thoracic duct is defined as a lymphatic vessel that is typically 5 to 7 mm wide and transports up to 4 liters of lymphatic fluid daily, arising from the ...
  37. [37]
    Lymphatic vessels balance viral dissemination and immune ...
    Sep 26, 2017 · Lymphatic vessels lie at the interface between peripheral sites of pathogen entry, adaptive immunity, and the systemic host.
  38. [38]
  39. [39]
  40. [40]
  41. [41]
    The Immunological Roles of the Lymphatic System - PubMed Central
    This review details the immune cell subsets in afferent and efferent lymph, and explores the mechanisms by which endothelial cells of the lymphatic system ...
  42. [42]
    Lymph node–resident lymphatic endothelial cells mediate ...
    Peripheral tolerance prevents self-reactive T cells that escape thymic negative selection from causing autoimmunity. Intrinsic mechanisms of peripheral ...
  43. [43]
  44. [44]
    Compartmentalization of Dendritic Cell and T cell Interactions in the ...
    For the induction of Th2 cell immune responses (left), Ag-containing migratory cDC2 cells arrive the LN subcapsular sinus via the lymph through afferent ...
  45. [45]
    Dendritic cell and antigen dispersal landscapes regulate T cell ...
    Spatial DC positioning and antigen dispersal in lymph nodes regulate T cell immunity, with asymmetric DC distribution causing regionalized T cell activation.
  46. [46]
    Dendritic cells and the handling of antigen - PMC - NIH
    Antigen presentation can lead either to priming of effector and memory T cells or to functional inactivation and T cell tolerance. Finding the factors that ...
  47. [47]
    Dynamics of B cells in germinal centres - PMC - NIH
    Humoral immunity depends on the germinal centre (GC) reaction during which somatically mutated high-affinity memory B cells and plasma cells are generated.
  48. [48]
    Lymphadenopathy - StatPearls - NCBI Bookshelf
    Lymphadenopathy is a common abnormal finding during the physical exam in general medical practice. It can be caused by neoplasm, inflammatory conditions, or ...Introduction · Pathophysiology · History and Physical · Differential Diagnosis
  49. [49]
    Adenopathy - StatPearls - NCBI Bookshelf - NIH
    Lymphadenopathy refers to the swelling of lymph nodes which can be secondary to bacterial, viral, or fungal infections, autoimmune disease, and malignancy.
  50. [50]
    Peripheral Lymphadenopathy: Approach and Diagnostic Tools - PMC
    Peripheral lymphadenopathy (LAP) is frequently due to a local or systemic, benign, self-limited, infectious disease. However, it could be a manifestation of ...
  51. [51]
    Progression of Metastasis through Lymphatic System - PMC
    Mar 12, 2021 · It has been shown that cancer cells can enter lymphatic vessels, migrate to tumor-draining lymph nodes (TDLNs) (Figure 1), grow into lesions in ...
  52. [52]
    Lymph node metastasis in cancer progression - Nature
    Sep 27, 2023 · It has been proved that lymph node metastasis (LNM) is an essential prognostic indicator in many different types of cancer.
  53. [53]
    Mechanisms of lymph node metastasis: An extracellular vesicle ...
    Lymph nodes act as sentinels of metastatic dissemination, the deadliest phase of tumor progression. Besides hematogenous dissemination, lymphatic spread of ...
  54. [54]
    Cancer Staging - NCI
    Oct 14, 2022 · The TNM Staging System · NX: Cancer in nearby lymph nodes cannot be measured. · N0: There is no cancer in nearby lymph nodes. · N1, N2, N3: Refers ...Diagnosis and Staging · Cancer Prognosis · How Cancer Is Diagnosed
  55. [55]
    TNM Classification - StatPearls - NCBI Bookshelf - NIH
    In colorectal cancer, N1 indicates the involvement of 1-3 regional nodes. N2 can be 4-6 regional nodes, while N3 indicates 7+ regional nodes involved. Nx is ...Definition/Introduction · Issues of Concern · Clinical Significance
  56. [56]
    Stages of cancer - Cancer Research UK
    Oct 10, 2023 · The TNM staging system · T describes the size of the tumour · N describes whether there are any cancer cells in the lymph nodes · M describes ...
  57. [57]
    Sentinel lymph node biopsy: What cancer patients should know
    Mar 7, 2024 · Sentinel lymph nodes are the first nodes that drain from a specific location in the body, and mapping them helps to identify the lymph nodes ...
  58. [58]
    Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick ...
    With a median follow-up of 36 months, the estimated 5-year disease-free, disease-specific, and overall survival rates were 47%, 74%, and 69%, respectively. A ...
  59. [59]
    What Is Metastasis? (Stage IV, Metastatic or Secondary Cancer)
    Metastasis happens when cancer cells break off from the original tumor, enter your bloodstream or lymphatic system, and then spread to other areas of your body.
  60. [60]
    Metastatic cancer: What happens when cancer spreads?
    May 25, 2021 · For example, breast cancer is more likely to spread to the nearby lymph nodes – a regional metastasis. Melanoma, lung, breast and kidney ...
  61. [61]
    Assessment of lymph node involvement in colorectal cancer - PMC
    Lymph node metastasis informs prognosis and is a key factor in deciding further management, particularly adjuvant chemotherapy.
  62. [62]
    Lymphedema - StatPearls - NCBI Bookshelf
    Apr 19, 2023 · Lymphedema is a chronic disease marked by the increased collection of lymphatic fluid in the body, causing swelling, which can lead to skin and tissue changes.Epidemiology · Pathophysiology · History and Physical · Treatment / Management
  63. [63]
    Lymphedema: Symptoms, Causes & Treatment - Cleveland Clinic
    What are lymphedema treatments? Lymphedema treatments vary depending on your condition's cause and stage. Treatments may include physical therapy or other ...
  64. [64]
    Lymphedema and Cancer - Side Effects - NCI
    Mar 6, 2024 · If cancer or cancer treatment disrupts the flow of lymph fluid or damages lymph nodes and vessels, lymph fluid may build up and cause lymphedema.What causes lymphedema? · How is lymphedema diagnosed?
  65. [65]
    Lymphangitis : MedlinePlus Medical Encyclopedia
    May 19, 2023 · Symptoms · Fever and chills · Enlarged and tender lymph nodes (glands) -- usually in the elbow, armpit, or groin · General ill feeling (malaise) ...
  66. [66]
    Lymphangioma - StatPearls - NCBI - NIH
    Lymphangiomas are uncommon, benign malformations of the lymphatic system that can occur anywhere on the skin and mucous membranes.<|control11|><|separator|>
  67. [67]
    Lymphedema - Diagnosis and treatment - Mayo Clinic
    Nov 24, 2022 · Damaged or removed lymph nodes can affect how lymph fluid drains. Fluid buildup leads to swelling. Treatments include compression and ...Diagnosis · Treatment · Preparing For Your...
  68. [68]
    Unexplained Lymphadenopathy: Evaluation and Differential Diagnosis
    Dec 1, 2016 · Fine-needle aspiration (FNA) and core needle biopsy can aid in the diagnostic evaluation of lymph nodes when etiology is unknown or malignant ...Missing: PET | Show results with:PET
  69. [69]
    PET-CT Imaging of Lymphoma - PMC - PubMed Central
    Overall, FDG PET is more sensitive and specific than CT in identifying lymphoma involved lymph nodes, except in the case of indolent lymphomas, which ...
  70. [70]
    Types of biopsy procedures used to diagnose cancer - Mayo Clinic
    such as a CT scan, MRI or ultrasound — with a needle biopsy. Image-guided biopsy ...
  71. [71]
    Lymph Node Biopsy: Procedure & Results - Cleveland Clinic
    Apr 2, 2024 · A provider makes a cut (incision) to access your lymph node and removes all of it (excisional biopsy) or part of it (incisional biopsy).Missing: MRI PET
  72. [72]
    Structure-function of the immune system in the spleen - PMC
    Sep 1, 2019 · Unlike lymph nodes (LNs), the spleen lacks afferent lymphatic vessels and therefore all cells and antigen enter the spleen via the blood.
  73. [73]
    Lymphatic System: Function, Conditions & Disorders
    You may be able to feel some lymph nodes through your skin, in areas like your armpits, groin or neck. Others are deeper inside your body. Spleen. This largest ...Missing: distribution | Show results with:distribution
  74. [74]
    Spleen - SEER Training Modules
    It is similar to a lymph node in shape and structure but it is much larger. The spleen is the largest lymphatic organ in the body.
  75. [75]
    Splenectomy - StatPearls - NCBI Bookshelf
    May 6, 2024 · Infections: the lifetime risk of OPSI is approximately 1% to 3%. · Cancer: splenectomized patients have an increased risk of cancer, as well as ...
  76. [76]
    A Contemporary, Population-Based Study of Lymphedema Risk ...
    The removal of 6-15 lymph nodes and 16 or more lymph nodes was associated with a 5-fold and 10-fold increased odds of developing lymphedema, respectively. The ...
  77. [77]
    Secondary Lymphoid Organs: Responding to Genetic and ...
    Secondary lymphoid organs (SLOs) include lymph nodes (LNs), spleen, Peyer's patches (PPs) and mucosal tissues- the nasal associated lymphoid tissue (NALT), ...Missing: comparison | Show results with:comparison
  78. [78]
    The development and function of mucosal lymphoid tissues - Nature
    Feb 26, 2014 · One important difference is that the generation of IgA-producing B cells is dependent on T cells in the Peyer's patches, while this is a T-cell ...Structure Of Mucosal... · Mucosal Lymphoid Organ... · Immunity In Ectopic Lymphoid...<|control11|><|separator|>
  79. [79]
    The evolution of nasal immune systems in vertebrates - PMC - NIH
    Examples of O-MALT include the Peyer's patches in the gut or the tonsils in the nasopharyngeal cavity. ... lymph nodes or O-MALT is an endotherm-restricted ...